the real reason for the surge is because patients are actually getting better
and the FDA has basically speeding up reviews, opening new approval routes, and using AI to process gene editing data faster
less waiting = less risk = more investor confidence
it feels like another one of those “this will change medicine” stories we hear every year
then suddenly… the charts wake up.
here’s the sector everyone ignored, but that could go big. really big. 🧵
and it’s not just AI
@IBM and @Cisco announced plans to build a quantum computing internet by the late 2030s
a long term bet that could redefine secure communication, scientific computing, and enterprise systems
if they pull it off, it becomes a strategic moat few can match.
some stocks fade into the background forever, but this one didn’t
it went from “old tech dinosaur” to a serious AI infrastructure powerhouse
here’s the story 🧵
If you want to track these shifts before the market reacts, you need a curated news feed that filters noise and shows only what matters to your bags.
read earlier, position smarter with Edgen News: https://t.co/1JWBh9UOdB
investors dumped the stock at first
but it rebounded once the AI numbers came out
meaning, markets no longer reward clean short-term profits, they reward long-term positioning.
if a company is building toward the next cycle, price always catches up late (you know what to do)
this quarter, @AlibabaGroup lost 72% of its profit…
but if you understand what REALLY happened, it tells you where AI, cloud, is heading next
let’s unpack👇